Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION, USP
Report ID | 148421 |
Drug Identification Number | 00872644 |
Brand name | AMPICILLIN SODIUM FOR INJECTION, USP |
Common or Proper name | AMPICILLIN SODIUM INJ 250MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AMPICILLIN |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10pk |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-10-26 |
Estimated end date | 2021-11-30 |
Actual end date | 2021-11-24 |
Shortage status | Resolved |
Updated date | 2021-11-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-10-28 | English | Compare |
v2 | 2021-10-28 | French | Compare |
v3 | 2021-11-25 | English | Compare |
v4 | 2021-11-25 | French | Compare |
Showing 1 to 4 of 4